Ortho Clinical Diagnostics Picks up EUA for COVID-19 Total Antibody Assay

FDA continues to grant Emergency Use Authorization during the coronavirus crisis. This time the federal agency has granted EUA to Ortho Clinical Diagnostics for a total antibody assay for COVID-19. The test is called the Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators. The Raritan, NJ-based company said its COVID-19 total antibody test can help determine who can responsibly be permitted to go back to work by aiding in the identification of currently infected or previously exposed individuals who may have developed an immunity. Ortho Clinical Diagnostics added that the test can also help screen plasma donations for convalescent plasma therapy, which helps critically ill patients fight the virus, help medical professionals and epidemiologists better understand the spread of the disease, and is an important tool for aiding vaccine development efforts to monitor immune responsiveness. When coupled with information from a molecular test, which detects active infection, it can monitor disease progression by measuring when antibodies appear in the blood. The firm said the test can be run on the Vitros XT 7600 Integrated System, the Vitros 3600 Immunodiagnostic System, the V5600 Integrated System and will soon be available on VECi/ECiQ Immunodiagnostic Systems. Vitros Systems, already installed in more than 1,000 hospitals and reference labs in the U.S., are self-contained and do not require an external water source to run, offering labs placement ...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Source Type: news